AI Science Tracker
EN

Identification of multiomics and immune infiltration-associated biomarkers for early gastric cancer: a machine learning-based diagnostic model development study

Laboratory Medicine Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China · 31 May 2025 · medicine

Discovery

Identification of multiomics and immune infiltration-associated biomarkers for early gastric cancer: a machine learning-based diagnostic model development study

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: serum-proteomic candidates to immune infiltration and report a glmBoost+XGBoost four-protein model (mean AUC 0.792); tissue qRT-PCR/IHC and external expression cohorts provide bounded checks. The paper notes inconsistent B2M/CFL1 expression in one validation cohort, so early-detection utility remains exploratory.

Technology: glmBoost and XGBoost four-protein classifier

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
glmBoost and XGBoost four-protein classifier
Limitation / still unknown
The study reports evaluation in the stated cohort, samples, datasets, or engineering setting; performance and practical benefit beyond that evaluated setting remain unknown.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12885-025-14396-2 · https://doi.org/10.1186/s12885-025-14396-2 · https://pubmed.ncbi.nlm.nih.gov/40450287/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.